GlassScriptPhysician profile
Jennifer Chiang
NPI 1457656738
$1,266.09
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $102 · 2021: $165 · 2022: $79.99 · 2023: $200 · 2024: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $403 · Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $403.25 |
| Food and Beverage | $318.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $287.99 | 2023-2024 | Tremfya |
| Vyne Pharmaceuticals INC. | $168.53 | 2020-2021 | |
| Dermira, INC. | $165.47 | 2019-2021 | |
| Dermavant Sciences, INC. | $146.50 | 2024 | Vtama |
| Sun Pharmaceutical Industries INC. | $124.69 | 2021-2023 | |
| Abbvie INC. | $109.89 | 2024 | |
| Stemline Therapeutics INC. | $86.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $79.99 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $61.85 | 2024 | Sotyktu |
| Biofrontera INC. | $19.86 | 2019 | |
| Pfizer INC. | $15.27 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Chiang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.